{
  "success": true,
  "pagesUsed": [
    2,
    4,
    10,
    12,
    15,
    17,
    20,
    25,
    27,
    29,
    32,
    37,
    39,
    40,
    41,
    42,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Zinc Washout Period",
        "type": {
          "id": "dee9f177-27ab-4085-8b6c-6c0e96d9a03a",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "52f06e18-8a93-4719-9229-d73006eabaf6",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "ec17c76e-dfee-44dc-a8ad-62869ba042e0",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_2",
        "name": "Chelator Washout Period",
        "type": {
          "id": "4797e9d7-7028-4f3e-87e5-4cd7a69538c4",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P4D",
        "valueLabel": "Day 4",
        "relativeToFrom": {
          "id": "6dfbd215-1714-46c3-b93c-0a30d2c0f9e8",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "6451d5ac-6353-4b62-9dcd-8a33e3ebdfd0",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_3",
        "name": "Experimental Therapy Washout",
        "type": {
          "id": "db3890ec-39e1-4f47-bcd0-b5ddb62dbcff",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P90D",
        "valueLabel": "Day 90",
        "relativeToFrom": {
          "id": "3e1c7710-f2ac-4ca1-8abc-bd73ecbccd03",
          "code": "C71158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "85b479dd-a2a0-4ec4-930a-b840805ac3b7",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_4",
        "name": "Prescription Medication Washout",
        "type": {
          "id": "b93547cf-677f-4da3-9f74-720f47629f7e",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "05efbdfe-9870-473d-b5d8-93fbcd6f2b10",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "4f1d5a42-4a73-491a-aa45-5756d220e8ff",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Non-Prescription Medication Washout",
        "type": {
          "id": "d06c8abe-5843-41fb-8b0e-ee7bd9280c80",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P7D",
        "valueLabel": "Day 7",
        "relativeToFrom": {
          "id": "8217ac7f-61ef-4d04-ab27-74d7c0a4c1e7",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "9aa9b627-adc6-4131-8032-22ed9f2e8319",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "End of Study Visit Window",
        "type": {
          "id": "d4e31ad1-857d-427f-b0e1-d47e586f0ecd",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P54D",
        "valueLabel": "Day 54",
        "relativeToFrom": {
          "id": "4b5f5aed-c4ba-439d-a454-df7bed2055ee",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "3dd0a64e-bf35-4743-9d5b-625c206e67aa",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_7",
        "name": "Initial Dosing Period (15 mg/day)",
        "type": {
          "id": "c66f55c9-f1ed-45a3-b14d-5a12a42ce2c8",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "Day 1",
        "relativeToFrom": {
          "id": "94ea1a6c-d816-4140-a552-237e7f8b3b1e",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "dbc65bbb-971b-4256-8738-5eae34ac442a",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_8",
        "name": "Titrated Dosing Period (30 mg/day)",
        "type": {
          "id": "a6b13efa-3925-426f-b1a9-f06dd0111aa8",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P29D",
        "valueLabel": "Day 29",
        "relativeToFrom": {
          "id": "a5ae886b-6805-495f-b03a-959292f7a4b3",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "b702b99f-1528-4c1b-bd64-e9a1e258bc56",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_9",
        "name": "Optional Outpatient Period Extension",
        "type": {
          "id": "65a45fb2-5372-4f82-8d9c-7202d5d09fe3",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "543aa6b3-5a5d-424c-ba08-357a66068ece",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "12471199-6d08-4926-9e88-3910d1895a11",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_10",
        "name": "Tetrathiomolybdate Washout Period",
        "type": {
          "id": "14440a10-7161-4d54-8f99-7dca34b71b50",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "1 years",
        "relativeToFrom": {
          "id": "6bf1b7e9-c87e-48af-83fa-a39d20ddbff8",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "a1ba1739-536c-4d9c-b2e5-e015fadd65ce",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Safety Review for Dose Titration",
        "instanceType": "Condition",
        "description": "Safety data must be reviewed by the Safety Review Committee (SRC) before dose titration.",
        "text": "Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data through Day 23 for each participant."
      },
      {
        "id": "cond_2",
        "name": "ALT Elevation (Severe)",
        "instanceType": "Condition",
        "description": "Criteria for dose modification due to severe ALT elevation.",
        "text": "ALT > 5 × ULN"
      },
      {
        "id": "cond_3",
        "name": "ALT Elevation (Moderate)",
        "instanceType": "Condition",
        "description": "Criteria for dose modification due to moderate ALT elevation.",
        "text": "ALT > 3 × ULN and ≤ 5 × ULN"
      },
      {
        "id": "cond_4",
        "name": "Low Platelet Count",
        "instanceType": "Condition",
        "description": "Criteria for dose modification due to low platelet count.",
        "text": "Platelets < 100,000/mm3"
      },
      {
        "id": "cond_5",
        "name": "Low Hemoglobin",
        "instanceType": "Condition",
        "description": "Criteria for dose modification due to low hemoglobin.",
        "text": "Hemoglobin < 10 g/dL"
      },
      {
        "id": "cond_6",
        "name": "Low Neutrophil Count",
        "instanceType": "Condition",
        "description": "Criteria for dose modification due to low neutrophil count.",
        "text": "Neutrophils > 30% ↓ from baseline and below reference range at baseline"
      },
      {
        "id": "cond_7",
        "name": "Potential Liver Injury (Hy's Law)",
        "instanceType": "Condition",
        "description": "Criteria for dose modification due to concurrent bilirubin and ALT elevation.",
        "text": "Bilirubin > 2 × ULN Accompanied by ALT > 3 × ULN, indicative of liver injury"
      },
      {
        "id": "cond_8",
        "name": "Neurologic Worsening",
        "instanceType": "Condition",
        "description": "Criteria for dose modification review due to neurologic worsening.",
        "text": "Evidence of neurologic worsening by AEs or by neurologic physical exam assessment"
      },
      {
        "id": "cond_9",
        "name": "Psychiatric Worsening",
        "instanceType": "Condition",
        "description": "Criteria for dose modification review due to psychiatric worsening.",
        "text": "Evidence of clinically significant acute psychiatric worsening which may include but not limited to suicidality, acute depression, or psychosis."
      },
      {
        "id": "cond_10",
        "name": "Mandatory Discontinuation Criteria",
        "instanceType": "Condition",
        "description": "Specific events that require consideration for study intervention discontinuation.",
        "text": "Serious hypersensitivity reaction; Severe uncontrolled infection; Use of disallowed medication; Pregnancy or planned pregnancy."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Dose Titration to 30 mg/day",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "fromElementId": "dose_15mg",
        "toElementId": "dose_30mg",
        "text": "Participants will be initiated on ALXN1840 at 15 mg once daily and increased to 30 mg once daily on Day 29, following a safety review."
      },
      {
        "id": "trans_2",
        "name": "Dose Interruption for Moderate ALT Elevation",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If ALT is > 3 × ULN and ≤ 5 × ULN, temporarily interrupt dosing."
      },
      {
        "id": "trans_3",
        "name": "Dose Discontinuation for Severe ALT Elevation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "If ALT is > 5 × ULN, discontinue study intervention."
      },
      {
        "id": "trans_4",
        "name": "Dose Reduction for Hematologic Toxicity",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Platelets < 100,000/mm3 or Hemoglobin < 10 g/dL, reduce dose to previous dose level."
      },
      {
        "id": "trans_5",
        "name": "Dose Reduction for Low Neutrophils",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Neutrophils > 30% ↓ from baseline, reduce dose to previous dose level if up-titration has occurred or reduce dose to 15 mg QOD if on 15 mg QD."
      },
      {
        "id": "trans_6",
        "name": "Dose Interruption for Potential Liver Injury",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Bilirubin > 2 × ULN accompanied by ALT > 3 × ULN, temporarily interrupt dosing."
      },
      {
        "id": "trans_7",
        "name": "Dose Modification for Neurologic/Psychiatric Worsening",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Investigator and Alexion Medical Monitor will evaluate the need for dose modification (interruption, increase or decrease) based on neurologic or psychiatric worsening."
      },
      {
        "id": "trans_8",
        "name": "Discontinuation for Specific Safety Events",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for: Serious hypersensitivity reaction; Severe uncontrolled infection; Use of disallowed medication; Pregnancy or planned pregnancy."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant is considered to have completed the study if he/she has completed all phases of the study including the last scheduled procedure shown in the Schedule of Activities (SoA)."
      },
      {
        "id": "exit_2",
        "name": "Participant Withdrawal of Consent",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may withdraw from the study at any time at his/her own request."
      },
      {
        "id": "exit_3",
        "name": "Investigator Discretionary Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may be withdrawn at any time at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons."
      },
      {
        "id": "exit_4",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      },
      {
        "id": "exit_5",
        "name": "Sponsor Termination of Study",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Alexion reserves the right to close the study site or terminate the study at any time for any reason at the sole discretion of Alexion."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Dose Titration Decision",
        "timepointId": "pt_day29",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point on Day 29 to titrate dose from 15 mg/day to 30 mg/day, contingent on a favorable safety review of data collected through Day 23.",
        "conditionIds": [
          "cond_1"
        ]
      },
      {
        "id": "dec_2",
        "name": "Ongoing Safety-Based Dose Modification",
        "timepointId": "pt_ongoing",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Ongoing assessment of safety laboratory parameters and clinical status at scheduled and unscheduled visits, which may trigger dose modifications (interruption, reduction) or discontinuation.",
        "conditionIds": [
          "cond_2",
          "cond_3",
          "cond_4",
          "cond_5",
          "cond_6",
          "cond_7",
          "cond_8",
          "cond_9"
        ]
      },
      {
        "id": "dec_3",
        "name": "Ongoing Discontinuation Review",
        "timepointId": "pt_ongoing",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Ongoing monitoring for specific events (e.g., hypersensitivity, pregnancy) that require consideration for permanent discontinuation of the study intervention.",
        "conditionIds": [
          "cond_10"
        ]
      }
    ],
    "summary": {
      "timingCount": 10,
      "conditionCount": 10,
      "transitionRuleCount": 8,
      "exitCount": 5
    }
  }
}